Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial

BACKGROUND: Treatment options for outpatients with COVID-19 could reduce morbidity and prevent SARS-CoV-2 transmission. METHODS: In this randomized, double-blind, three-arm (1:1:1) placebo-equivalent controlled trial conducted remotely throughout the United States, adult outpatients with laboratory-...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Christine, Brown, Elizabeth R., Stewart, Jenell, Karita, Helen C.Stankiewicz, Kissinger, Patricia J., Dwyer, John, Hosek, Sybil, Oyedele, Temitope, Paasche-Orlow, Michael K., Paolino, Kristopher, Heller, Kate B., Leingang, Hannah, Haugen, Harald S., Dong, Tracy Q., Bershteyn, Anna, Sridhar, Arun R., Poole, Jeanne, Noseworthy, Peter A., Ackerman, Michael J., Morrison, Susan, Greninger, Alexander L., Huang, Meei-Li, Jerome, Keith R., Wener, Mark H., Wald, Anna, Schiffer, Joshua T., Celum, Connie, Chu, Helen Y., Barnabas, Ruanne V., Baeten, Jared M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912360/
https://www.ncbi.nlm.nih.gov/pubmed/33681731
http://dx.doi.org/10.1016/j.eclinm.2021.100773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912360/
https://www.ncbi.nlm.nih.gov/pubmed/33681731
http://dx.doi.org/10.1016/j.eclinm.2021.100773

Ejemplares similares